CMS Open Payments · Program Year 2024
Sequel Med Tech, LLC
Sequel Med Tech, LLC reported $5,052.31 across General Payments, Research, and Ownership to 64 physicians and teaching hospitals across 64 transactions.
- $5.1K
- All-tracks total
- 64
- Transactions
- 64
- Recipients
- #1709
- of 1,925 companies
Sequel Med Tech, LLC reported $5,052.31 across all CMS Open Payments tracks (General + Research + Ownership) to 64 physicians and teaching hospitals in Program Year 2024 - ranking #1709 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $5,052.31, averaging $78.94 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer sequel-med-tech-llc Sequel Med Tech, LLC
$5.1K · #1709/1,925 · 0.0% industry · PY2024
- TOT $5.1K
- RANK #1709
- SHARE 0.0%
- TXN 64
- RCP 64
- CAT 3
- GEN $5.1K
- TOP1 35.3%
- PY 2024
Volume peers
Nearest volume peer: Alcon Puerto Rico Inc ($5.0K)
Sequel Med Tech, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Sequel Med Tech, LLC
$5,052.31: that is what Sequel Med Tech, LLC reported in payments to 64 physicians and teaching hospitals during Program Year 2024, spread across 64 transactions ($78.94 per transaction, $78.94 per recipient). The company sits at rank #1709 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
4 transactions worth $2.5K make "Consulting Fee" the top general-payment category in the 3-category breakdown below, 49.5% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Sequel Med Tech, LLC made 3 types of general payments. "Consulting Fee" is the largest category at $2.5K, 49.5% of General Payments.
How Sequel Med Tech, LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $2.5K | 4 | 49.5% |
| Food and Beverage | $2.3K | 59 | 44.9% |
| Travel and Lodging | $283.98 | 1 | 5.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $2,918.61 (57.8%) of $5,052.31 in this company's General Payments records across 63 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Sequel Med Tech, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Viral Shah
$1,783.98 across 2 reported transactions
- 2
Eugene Wright
$500.00 across 1 reported transactions
- 3
Jennifer D Becker
$250.00 across 1 reported transactions
- 4
Lauren M Sosdorf
$250.00 across 1 reported transactions
- 5
Anastasios Manessis
$134.63 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Sequel Med Tech, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Sequel Med Tech, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Sequel Med Tech, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Genetics Institute LLC
Hand Biomechanics Laboratory
The Binding Site Inc.
Fusion Orthopedics, LLC.
Vifor Fresenius Medical Care Renal Pharma Ltd.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.